Nantes - Systemy Nanotechnologiisp. z o.o.

Other research and experimental development on natural sciences and engineering

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2007-04-06
Activity description

Nantes - Systemy Nanotechnologii is a company that specializes in nanotechnology and the study of water structure, particularly through the development of plasma water with unique properties. They also produce lavender hydrolat, which has skin care benefits and is used in phytotherapy for digestive issues. Their products aim to improve health and enhance the quality of life.

Registered address
ul. Mostowa 1, 59-700 Bolesławiec, Poland
Website
nantes.com.plWebsite active
Email
Email warning
Phone
Social media
Electronic delivery address
AE:PL-59673-98069-UJFGD-27

Financials

The financial statement for 2025 has not yet been filed with the Financial Document Repository (past deadline).

Revenue history (in k)

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2024.

Results vs industry

Revenue
This companyUSD 191.24kMedianUSD 72.15kAverageUSD 3.22m
Net profit
This companyUSD -34.76kMedianUSD 87.69AverageUSD 112.20k
Operating costs
This companyUSD 214.67kMedianUSD 75.02kAverageUSD 3.02m
Assets
This companyUSD 263.92kMedianUSD 121.49kAverageUSD 3.89m

Bank accounts

Registered as a VAT taxpayer on 2007-04-12. Active

Debt

2 active proceedings recorded in KRZ. Active proceeding

Registration dateProceeding typeStatus
Nov 12, 2025
Bankruptcy proceedings for an entrepreneur
In progress
May 28, 2025
Petition to declare entrepreneur bankruptcy
Closed

Public aid

5 public aid cases recorded, with a total value of $33,165.

PurposeGross amount
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$1,112
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$1,112
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$1,282

Tenders

No recorded participation in tenders.

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Authorized Representatives

Igor Dovydenko — President of the Management Board

Manner of representation

The company may make declarations of will through the President of the Management Board independently on each occasion, whereas declarations of will resulting in the incurring of liabilities exceeding twice the amount of the share capital require joint action by the President of the Management Board and one member of the management board.

Ownership

OwnerSharesShare valueStake
Dmitrij Dovydenko (23)
20$2,701.2420%
Igor Dovydenko (54)
80$10,804.9780%

Igor Dovydenko and Dmitrij Dovydenko hold a combined 100% – the ownership structure indicates family control.

Beneficial owners

Person
Igor Dovydenko (54)
Izabela Skonieczna-Powałka (51)

Competitors

Name
RDLSsp. z o.o.
Syventosp. z o.o.
Medicofarma BiotechS.A.
Innovatronicasp. z o.o.
NanosanguisS.A.
Nexbiosp. z o.o.
Energia Nowasp. z o.o.
Stenocoatsp. z o.o.
NanovelosS.A.

Change history

DateEvent
2026-03-13Name change
2023-07-17Address change
2022-10-21PKD change
2022-01-24PKD change
2018-09-10PKD change

FAQ

Last updated: 2026-03-25